Stocktoria
Hangzhou Tigermed Consulting Co., Ltd 300347.SZ
Hangzhou Tigermed Consulting Co., Ltd statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (CN¥25.78); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Hangzhou Tigermed Consulting Co., Ltd trades at about 53.9× earnings — below its 10-year norm (10-year range 17.4×–104.3×, median 60.6×).
Shaded band = 10-year range (17.4×–104.3×); dot = today's 53.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 27.4% | 34.0% | 38.6% | 39.6% |
| Operating margin | 9.8% | 16.2% | 23.8% | 25.6% |
| Net margin | 13.0% | 6.1% | 27.4% | 28.3% |
| FCF margin | 13.2% | 11.2% | 11.3% | 12.8% |
| Return on assets | 3.1% | 1.4% | 6.8% | 7.3% |
| Return on equity | 4.2% | 2.0% | 9.6% | 10.2% |
| Debt / equity | 0.03× | 0.02× | 0.02× | 0.01× |
| Current ratio | 2.18 | 1.72 | 2.74 | 2.98 |
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.